Drug Shortage Report for TEVA-LENOLTEC NO. 1

Last updated on 2020-07-23 History
Report ID 97594
Drug Identification Number 00653233
Brand name TEVA-LENOLTEC NO. 1
Common or Proper name LENOLTEC NO.1 CAPLETS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE
Strength(s) 300MG 8MG 15MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's & 200's
ATC code N02AJ
ATC description OPIOIDS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-10-31
Estimated end date 2020-07-31
Actual end date 2020-07-22
Shortage status Resolved
Updated date 2020-07-23
Company comments Allocating to 100% of our market.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-10-31 English Compare
v2 2019-10-31 French Compare
v3 2019-10-31 English Compare
v4 2019-10-31 French Compare
v5 2019-11-01 English Compare
v6 2019-11-07 English Compare
v7 2019-11-07 French Compare
v8 2019-11-21 English Compare
v9 2019-11-21 English Compare
v10 2019-11-21 French Compare
v11 2019-11-28 English Compare
v12 2019-11-28 French Compare
v13 2019-12-12 English Compare
v14 2019-12-12 French Compare
v15 2020-01-30 English Compare
v16 2020-01-30 French Compare
v17 2020-02-07 English Compare
v18 2020-02-07 French Compare
v19 2020-03-05 English Compare
v20 2020-03-05 French Compare

Showing 1 to 20 of 32